Efficacy of Treatment for Generalized Anxiety Disorder

Generalized Anxiety Disorder Clinical Trial

Official title:

Efficacy of Treatment for Generalized Anxiety Disorder

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00456742
• Other study ID #: H06-80375
• Status: Completed
• Phase: N/A
• First received: April 3, 2007
• Last updated: April 30, 2012
• Start date: June 2006
• Est. completion date: December 2009

Study information

• Verified date: April 2012
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Observational

Clinical Trial Summary

The purpose of these questionnaires is to give us an overview of how GAD has affected your life, and perhaps also to give us some clues about things that may have set you up to experience GAD.

Description:

For us to evaluate the efficacy of our treatment programs, we are interested in your responses before and after treatment. We use two methods to evaluate the efficacy of our treatments: questionnaires and interviews with a member of the Anxiety Disorders Clinic. As part of standard clinic procedure, each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment. If you have received this questionnaire packet, it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic. The purpose of the questionnaire packet is to assess the severity of your generalized anxiety disorder; its impact on your functioning, and factors that may contribute to the onset or maintenance of your GAD (e.g., depression, intolerance of uncertainty). We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 250
• Est. completion date: December 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 19 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patients referred to the Anxiety Disorders Clinic who receive a primary diagnosis of Generalized Anxiety Disorder, and are accepted for treatment at the clinic.

Exclusion Criteria:

• Individuals who either have not sought treatment for anxiety at the Anxiety Disorders Clinic or patients who did not receive a primary diagnosis of Generalized Anxiety Disorder.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Anxiety Disorders
• Generalized Anxiety Disorder

Locations

Country	Name	City	State
Canada	Anxiety Disorders Clinic, University of British Columbia	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada,